職稱：副主任醫師專長：從事18歲以下的兒童、青少年惡性腫瘤的化學治療?出診時間：每周二上午??????????????? 每周五下午教育經歷：　　2016年獲中山大學腫瘤學博士學位工作經歷：　　2006-07至2011-02 中山大學附屬第一醫院兒科　　2011-03至今 中山大學腫瘤防治中心兒童腫瘤科????2019.10-2020.10 美國MD?Anderson癌癥中心博士后發表文章：1 Sun F, Zhu J(共同第一作者), Lu S, Zhen Z, Wang J, Huang J, Ding Z, Zeng M, Sun X. An inflammation-based cumulative prognostic score system in patients with diffuse large B cell lymphoma in rituximab era.[J].BMC Cancer. 2018 Jan 2;18(1):5.2 Zhu J, Wang J, Zhen ZJ, et al. Brain metastasis in children with stage 4 neuroblastoma after multidisciplinary treatment[J]. Chin J Cancer. 2015,14;34(3):49.3 Zhu J, Zhang Y, Zhen ZJ,et al.Lymphoma and cerebral vasculitis in association with X-linked lymphoproliferative disease[J]. Chin J Cancer, Chin J Cancer,2013,32(12):673-677.4朱佳，甄子俊，王娟，等.中危神經母細胞瘤患者臨床和生存分析[J]. 中國小兒血液與腫瘤雜志.2016,3:117-121.5 Zhu J, Chen H, Chen T, Zhen Z, Wang J, Sun F, Lu S, Huang J, Zhang Y, Sun X. Multimodal Treatment of Children With Sacrococcygeal Yolk Sac Tumor: Retrospective Analysis of Clinicopathology Characteristics and Relapse-free Survival. J Pediatr Hematol Oncol. 2021 Jan 27. doi: 10.1097/MPH.0000000000002068. Epub ahead of print. PMID: 33512871.6 Jia Zhu, Zijun Zhen, Juan Wang, et al. Outcomes of Burkitt Lymphoma with Bone Marrow Involvement or Burkitt Leukemia in Chinese Children: A Single-CentRetrospective Analysis[J]. Pediatr er Investigation. Accepted.

從事18歲以下的兒童、青少年惡性腫瘤的化學治療